Dr. Zhao has assembled the top experts in the field of urology to present state-of-the-art clinical reviews devoted to Male Urethral Reconstruction and the Management of Urethral Stricture Disease. The issue is divided into three sections, with focus on evlaluation and follow up, urethroplasty technique, and conditions affecting outcomes. Authors have specifically addressed the following topics: Definition of successful treatment and optimal follow up in urethral strictures; Cost analyses for evaluation and treatment of urethral strictures; Sexual dysfunction after urethroplasty; Endoscopic treatment of urethral stricture; Endoscopic treatment for urethral stenosis; Patient selection for urethroplasty technique: EPA vs Graft; Effect of graft location in urethroplasty; Non-transecting urethroplasty; Urethroplasty for panurethral urethral stricture; Use of alternative graft material in urethroplasty; Effect of Lichen Sclerosis on success of urethroplasty; Treatment of radiation induced urethral strictures; Effect of artificial urethral sphincters on strictures; Urethral strictures after transgender surgery; and Management of urethral strictures after hypospadias repair. Readers will come away with the current clinical diagnosis and management strategies that they can employ immediately.

This issue of Surgical Pathology Clinics focuses on diseases of the genitourinary tract: Prostate, Kidney, Bladder, Testes, and Adrenals. As with all information in this series, presentations relate to the daily practice of surgical pathologists. A practical and innovative feature in this issue is the inclusion of several articles from the "clinician's perspective" in which an oncologist discusses the diagnosis of the disease and relates this to the information they require from the pathologist. Topics include: Morphologic updates in prostate pathology; Molecular updates in prostate pathology; Diagnosis of prostate carcinoma: A clinician's perspective; Commonly encountered renal neoplasms; Emerging dntities in renal neoplasia; Diagnosis of renal cell carcinoma: A clinician's perspective; Morphologic and molecular characteristics of bladder cancer; Diagnosis of bladder carcinoma: A clinician's perspective; Overview of testicular neoplasia; Diagnosis of testicular cancer: A clinician's perspective; Overview of adrenal neoplasia; Diagnosis of adrenal carcinoma: A clinician's perspective; Benign lesions of the GU tract . Michelle Hirsch leads this issue with a group of expert genitourinary pathologists and oncologists.

This issue provides much needed updates since Dr. Sheinfeld's issue published in 2007. Dr. Lin has assembled expert authors to provide clinicians with the full breadth of clinical updates on testicular cancer. New to this issue are articles on clinical outcomes, survivorship, and several articles on the management of Nonseminomatous Germ Cell Tumors.

This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.

Each year nearly 35,000 men are diagnosed with prostate cancer. Of these, more than 10,000 die from the disease, and figures are rising. But better awareness, earlier diagnosis and more sophisticated treatments can save lives, and have already reduced death rates in some countries. This new edition of Coping Successfully with Prostate Cancer presents the latest research on prostate cancer and describes the many treatments available. Topics include; symptoms and stages of the disease, other prostate problems, the possible influence of diet, geography and viral factors, screening and investigation, including PSA, the decision to treat, or not to treat, treatments, including surgery and radiation therapy, branchytherapy and laser, dealing with advanced prostate cancer, lifestyle measures, coping with sex, research and the future. In this thoroughly updated and positive book, Dr Tom Smith says that it is possible for men with prostate cancer to lead successful, happy and fufilled lives.

In consultation with Consulting Editor, Dr. Samir Taneja, Dr. Sia Daneshmand has put together a state-of the-art issue of the Urologic Clinics devoted to Modern Management of Testicular Cancer. The issue focuses on surgical techniques and diagnostic modalities for testicular cancer. Clinical review articles are specifically devoted to the following: Imaging For Testicular Cancer; Management of Stage I Germ Cell Tumors; Management of Stage II Germ Cell Tumors; Current Management Of Disseminated GCT; Post-Chemotherapy Resection of Residual Mass in NSGCT; Indications For Surgery in Disseminated Seminoma; Growing Teratoma Syndrome; Management of The Primary Testicular Tumor; High-Dose Chemotherapy and Autologous Stem Cell Transplantation; mRna As Biomarkers For Germ Cell Tumors; Minimally Invasive RPLND: Is There a Role?; Complications of RPLND; Preservation of Fertility in Testis Cancer Management. Readers will come away with the latest information they need to optimize surgical and management outcomes in the patient with testicular cancer.

The FRCS (Urol) - Urology and urological surgery - is the mandatory final exit exam that all urology national training number (NTN) trainees in the UK must successfully complete in order to achieve Certification of Training (CCT) in urology. The FRCS (Urol) exam is run by the four Royal Colleges of Surgery of the UK and Ireland, with the Joint Committee on Surgical Training (JCST) acting as advisory body. Internationally the FRCS (Urol) as a qualification is widely recognised as a marker of quality and indeed applicants from all around the world sit the exam. The FRCS (Urol) consists of a first written component, followed at a later date by a separate oral viva examination. There is an impending lack of published textbooks that provide a comprehensive summary of the knowledge required to pass the exam. This textbook, along with Book 1, fills the current market gap of a dedicated revision note style book to prepare candidates for the FRCS (Urol), as well as educate more junior trainees starting their higher training in urology.

In this issue of Urologic Clinics of North America, guest editor Dr. Kevin R. Loughlin brings his considerable expertise to the topic of Testosterone. With about 2 out of 10 men older than 60 years having low testosterone (American Urological Association), coupled with an aging population, this issue is an important resource for all urologists for effectively treating men and improving outcomes. It provides a current update on testosterone in men from top experts in the field, covering prostate cancer treatment, the use of anabolic steroids, hypogonadism, testosterone replacement, and more. Contains 15 practice-oriented topics including current management and controversies surrounding andropause; testosterone and male sexual function; the interplay of testosterone and dihydrotestosterone in prostate cancer; and more. Provides in-depth clinical reviews on testosterone, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

The FRCS (Urol) - Urology and urological surgery - is the mandatory final exit exam that all urology national training number (NTN) trainees in the UK must successfully complete in order to achieve Certification of Training (CCT) in urology. The FRCS (Urol) exam is run by the four Royal Colleges of Surgery of the UK and Ireland, with the Joint Committee on Surgical Training (JCST) acting as advisory body. Internationally the FRCS (Urol) as a qualification is widely recognised as a marker of quality and indeed applicants from all around the world sit the exam. The FRCS (Urol) consists of a first written component, followed at a later date by a separate oral viva examination. There is an impending lack of published textbooks that provide a comprehensive summary of the knowledge required to pass the exam. This textbook, along with Book 2, fills the current market gap of a dedicated revision note style book to prepare candidates for the FRCS (Urol), as well as educate more junior trainees starting their higher training in urology.

In this issue of Urologic Clinics of North America, guest editor Dr. Jill Buckley brings her considerable expertise to the topic of Urologic Reconstructive Surgery. This complex area draws upon the fields of urology, plastic surgery, and even colorectal surgery. In this issue, top experts address the wide breadth of reconstructive surgeries that a urologist may be called upon to perform, providing current, evidence-based clinical and surgical information to improve outcomes. Contains 14 relevant, practice-oriented topics male stress urinary incontinence; gender affirmation surgery: male to female; gender affirmation surgery: female to male; robotic lower urinary tract reconstructive surgery; selection and outcomes of urinary bowel diversions; and more. Provides in-depth clinical reviews on urologic reconstructive surgery, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies for benign prostatic hyperplasia, erectile dysfunction, hypogonadism, overactive bladder, and prostate cancer are widely available, and a basic understanding of the pharmacology of existing treatment options are necessary to avoid complications and maximize efficacy associated with patient outcomes. In this issue, top experts in the field provide current clinical information to help urologists effectively and quickly treat patients. Contains 14 relevant, practice-oriented topics including medical treatment for benign prostatic hyperplasia, medical treatment for urinary tract infections, nutraceuticals and phytotherapy in men's health, hormonal therapy for prostate cancer, medical treatment of female sexual dysfunction, and more. Provides in-depth clinical reviews on urologic pharmacology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Scientific Advances in Reconstructive Urology and Tissue Engineering is a comprehensive overview of reconstructive urology that spans male and female, pediatric, neuro-urology and trauma. Traditionally, this field has been focused solely on surgical principles with little attention to basic and translational research. However, recent advances in acellular matrices, scaffolds, stem cells and tissue engineering have changed this focus. This publication is the perfect bridge and definitive tome of the advances that will move the translational and basic science of reconstructive urology forward and allow readers to implement the findings in clinical practice. Through the use of both current case studies and future implications, the content bridges the gap from bench to bedside making it the perfect reference for translational benign urology researchers who wish to move the field of reconstructive surgery forward.

This issue of Urologic Clinics provides the urologist with important updates to better manage patients requiring minimally invasive procedures. Top experts in the field cover key topics such as Focal Therapy in Urology, Advances in Ureteroscopy, New Stent Technologies, and more. Provides in-depth, clinical reviews on minimally invasive urology, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Contains 12 relevant, practice-oriented topics including New Lasers for Kidney Stone Treatment; New Technologies for Treatment of BPH; Technology for 3D Printing and Simulation; Artificial Intelligence: Applications in Urology; Disposable Endoscopes in Urology: Current State and Future Prospects; and more.

In this issue of Urologic Clinics, Guest Editors Alan W Shindel and Tom F. Lue bring their considerable expertise to the topic of Sexual Dysfunction. Top experts in the field cover key topics such as Sexual Wellness in transgender persons; Energy-based Therapies for ED; Oncology Survivorship and Sexual Wellness for Men and Women; Sexual Wellness in Gay, Lesbian, and Bisexual Patients; and more. Provides in-depth, clinical reviews in Sexual Dysfunction, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Contains 16 relevant, practice-oriented topics including Management of Penile Fracture; Physiology of Erection and Pathophysiology of Erectile Dysfunction; Stem Cell and Gene-Based Therapy for ED; Management of Priapism; and more.

These proceedings of the 2018 XIII International Symposium on Spermatology focus on comparative biology, and encourages discussion and the exchange of ideas. The aim of this Symposium was to provide a unique opportunity and bring together scientists from a wide spectrum of research fields - human, domestic animals and other mammals, vertebrates, insects, and plants. The underlying focus is on the function of the spermatozoon - a common feature for sexual reproduction, but extremely varied. By exploring the variability, a better understanding of male reproductive functions can develop. These proceedings address the mechanisms of physiology and pathophysiology, rather than diagnosis and treatment. The symposium featured keynote lectures by invited speakers, followed by presentations on specific aspects of the general topic of the session. Experimental studies are given priority over clinical studies of patient populations. The proceedings comprise both keynote speakers' texts and selected free communications. Posters were considered for publication in the proceedings, and the volume includes exhibited materials on the work of prominent spermatologists, highlighting their important past achievements in the field.

The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on the following topics: Era of personalized vaccines for GU cancers; TCR and dendritic vaccine platforms for GU cancers; Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing in Cancer: Role of tumor microenvironment and immune-suppressive pathways in localized and aggressive disease; Clinical integration of neo-adjuvant platforms for prostate cancer immunotherapy; Immunotherapy for muscle and non-muscle invasive bladder cancer: BCG and beyond; Immunotherapy for metastatic bladder cancer; Immunotherapy options for metastatic castrate-resistant prostate cancer; Role of tissue infiltrating lymphocytes: Understanding TCR; Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in prostate cancer: Underlying causes and influence on response to immunotherapy; and Racial disparity in response to immunotherapy. Urologists will come away with the most current information they need to improve outcomes in the urologic cancer patient.